Welcome to the international HTA database

Showing [16409 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2009	Penn Medicine Center for Evidence-based Practice (CEP)	Prevention and management of delirium
2009	HAYES, Inc.	Endoscopic retrograde cholangiopancreatography for the treatment of benign and malignant diseases of the pancreas and biliary tree
2009	Blue Cross Blue Shield Association (BCBS)	Artificial intervertebral disc arthroplasty for treatment of degenerative disc disease of the cervical spine
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[AUDIT ONCOrisk: Quality of the information in the study about digestive oncological surgery results]
2009	VA Technology Assessment Program (VATAP)	Regionalization of surgical services
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Addendum to the Canadian Agency for Drugs and Technologies in Health guidelines for the economic evaluation of health technologies: specific guidance for oncology products
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Aortoiliofemoral arteriogram-guided peripheral vascular stenting: a review of the clinical and cost-effectiveness
2009	National Institute for Health and Care Excellence (NICE)	Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma. NICE technology appraisal guidance 178
2009	Agency for Healthcare Research and Quality (AHRQ)	Horizon Scan: to what extent do changes in third-party payment affect clinical trials and the evidence base
2009	HAYES, Inc.	Endovenous laser therapy for varicose veins due to great saphenous vein reflux
2009	Blue Cross Blue Shield Association (BCBS)	Off-label use of bevacizumab: advanced adenocarcinoma of the pancreas
2009	HAYES, Inc.	Nanoparticle-based cancer therapies: Albumin-bound paclitaxel
2009	VA Technology Assessment Program (VATAP)	Simulation training
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Radioimmunotherapies for non-hodgkin lymphoma: systematic review of clinical effectiveness, cost-effectiveness, and guidelines
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Endovascular coiling versus surgical clipping: a review of the clinical and cost-effectiveness
2009	National Institute for Health and Care Excellence (NICE)	Tenofovir disoproxil for the treatment of chronic hepatitis B. NICE technology appraisal guidance 173
2009	HAYES, Inc.	Endovenous laser therapy for varicose veins due to small saphenous vein reflux
2009	Blue Cross Blue Shield Association (BCBS)	Transcranial magnetic stimulation for depression
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Recombinant activated Factor VII in treatment of hemorrhage unrelated to hemophilia: a systematic review and economic evaluation
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Carotid artery stenting versus carotid endarterectomy: a review of the clinical and cost-effectiveness
2009	National Institute for Health and Care Excellence (NICE)	Rituximab for the first-line treatment of chronic lymphocytic leukaemia. NICE technology appraisal guidance 174
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Development of a shared knowledge system for network assessment of technological innovation in medicine]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Drugs for pulmonary arterial hypertension: a systematic review of the clinical-effectiveness of combination therapy
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Elective endovascular abdominal aortic aneurism repair versus open surgery: a review of the clinical and cost-effectiveness
2009	National Institute for Health and Care Excellence (NICE)	Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults. NICE technology appraisal guidance 170
2009	Technology Assessment Unit of the McGill University Health Centre (MUHC)	[The use of carmustine implants (Gliadel wafers) in patients with malignant glioma]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sterilization of foot care instruments: a review of the guidelines
2009	National Institute for Health and Care Excellence (NICE)	Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma. NICE technology appraisal guidance 169
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Effectiveness of the filum terminale section for the treatment of Chiari I malformation]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Intravenous immunoglobulin for chronic inflammatory demyelinating polyneuropathy: Clinical- and cost-effectiveness analyses
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Universal, community-based developmental screening tools for children 6 years and younger: a review of clinical effectiveness
2009	National Institute for Health and Care Excellence (NICE)	Amantadine, oseltamivir and zanamivir for the treatment of influenza. NICE technology appraisal guidance 168
2009	Health Information and Quality Authority (HIQA)	Health technology assessment (HTA) of a population-based colorectal cancer screening programme in Ireland
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Hadrontherapy in the treatment of cancer]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Resin-bonded fixed bridges and conventional fixed bridges: a review of the advantages and disadvantages and indications
2009	National Institute for Health and Care Excellence (NICE)	Machine perfusion systems and cold static storage of kidneys from deceased donors. NICE technology appraisal guidance 165
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Health and health services use in immigrant and native population in Spain]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Foot care for patients with peripheral vascular disease: a review of the guidelines
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Spiral Laminar Flow bypass graft for peripheral arterial disease
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Urine based testing for gonorrhea and chlamydia: a review of diagnostic accuracy, cost-effectiveness, and compliance
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Pregabalin (Lyrica) for partial onset epilepsy - monotherapy
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Naltrexone for the treatment of alcohol dependence in individuals with co- dependencies: a review of the clinical effectiveness
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Dasatinib (Sprycel) for chronic myeloid leukaemia - first line
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Influence of an existing health care plan aimed at managing ST-elevation myocardial infarction on the waiting time until re-perfusion, and types of re-perfusion. Pilot study]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Naltrexone in combination with acamprosate for the treatment of alcohol dependence: a review of the clinical and cost-effectiveness
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Carisbamate for partial onset epilepsy
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Lower respiratory tract infections of a viral origin in the paediatric population: systematic review of Spanish literature]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Organic acid testing for autism: a review of the diagnostic accuracy
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Everolimus for autosomal dominant polycystic kidney disease with renal impairment
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Miglustat (Zavesca) in the treatment of Niemann-Pick type C disease]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Low molecular weight heparins versus unfractionated heparin for thromboprophylaxis: a review of the cost-effectiveness
2009	Andalusian Health Technology Assessment Area (AETSA)	[Endovascular treatment for thoracic aorta lesions]
2009	NIHR Horizon Scanning Centre (NIHR HSC)	HandTutor for hand rehabilitation
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Overweight in the teenager population: quality of life, access to health care services and cost-effectiveness of interventions]
2009	HAYES, Inc.	Hunter Syndrome (Mucopolysaccharidosis Type II, MPS II)
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Intraperitoneal chemotherapy for ovarian cancer patients: a review of the clinical and cost-effectiveness
2009	HAYES, Inc.	Hyperbaric oxygen therapy for soft tissue radiation injuries
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Teduglutide for short bowel syndrome
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Trabectedin (Yondelis) in the treatment of soft tissue sarcomas]
2009	Norwegian Knowledge Centre for the Health Services (NOKC)	[The diagnostic accuracy of infrared tympanic, oral, axillary and temporal thermometry, compared with rectal readings when identifying fever in adult hospitalized patients]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Celecoxib for post-operative pain management: a review of the clinical benefit and harm
2009	Agency for Healthcare Research and Quality (AHRQ)	Complementary and alternative medicine in back pain utilization report
2009	HAYES, Inc.	Hyperbaric oxygen therapy for osteoradionecrosis
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Tapentadol (Palexia) prolonged-release for severe chronic pain
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Indirect evidence: indirect treatment comparisons in meta-analysis
2009	Norwegian Knowledge Centre for the Health Services (NOKC)	[Long term institutional or residential treatment of patients with substance abuse compared to short-term outpatient treatment]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Oral care sponges for long-term care patients: a review of the clinical-effectiveness
2009	Medical Services Advisory Committee (MSAC)	Real-time measurement of cardiac output and other cardiac flow parameters (without concurrent cardiac imaging) using continuous wave Doppler techniques
2009	Institute of Health Economics (IHE)	Human papillomavirus (HPV) testing in Alberta
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Bioresonance for allergies, atopic dermatitis, non-organic gastrointestinal complaints, pain and rheumatic diseases
2009	HAYES, Inc.	Imageless computer-assisted surgery for total knee replacement
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Tapentadol (Palexia) for severe acute pain
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Portable ultrasonography in small emergency departments: a systematic review of the guidelines and clinical-effectiveness
2009	Norwegian Knowledge Centre for the Health Services (NOKC)	[Methylnaltrexone for opioid-induced constipation in cancer treatment]
2009	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Pumpless extracorporeal lung assist device (Novalung)
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Botulinum toxin A for the treatment of trigeminal neuralgia and temporomandibular joint dysfunction: a review of the clinical-effectiveness
2009	Health Technology and Policy Unit (HTPU)	Photodynamic therapy for the treatment of early esophageal cancer: a systematic review and economic evaluation
2009	NIHR Health Technology Assessment programme	Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE)
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Colon hydrotherapy for defecation disorders. Systematic Review
2009	HAYES, Inc.	Inhaled nitric oxide for the treatment of persistent pulmonary hypertension in term and near-term newborns
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Rituximab (Rituxan/MabThera) for the first- and second-line treatment of chronic lymphocytic leukaemia
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Ridaforolimus for unresectable locally advanced and metastatic soft tissue and bone sarcoma - maintenance therapy
2009	Adelaide Health Technology Assessment (AHTA)	A toolkit for the identification and assessment of new and emerging health technologies
2009	Norwegian Knowledge Centre for the Health Services (NOKC)	Effectiveness of interventions designed to reduce the prevalence of female genital mutilation/cutting
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pelvic floor repair systems: a review of the clinical-effectiveness, cost- effectiveness, and guidelines
2009	Health Technology and Policy Unit (HTPU)	Photodynamic therapy for the treatment of barrett's esophagus: a systematic review and economic evaluation
2009	Medical Services Advisory Committee (MSAC)	Automation-assisted and liquid-based cytology for cervical cancer screening
2009	Institute of Health Economics (IHE)	Effectiveness of organizational interventions for the prevention of stress in the workplace
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	International comparison of antenatal care in pregnant women
2009	HAYES, Inc.	Inhaled nitric oxide for the treatment of respiratory failure in term and near-term newborns
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Ibritumomab tiuxetan (Zevalin) as consolidation therapy after first remission in patients with follicular lymphoma
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Pixantrone dimaleate for relapsed or refractory aggressive non-Hodgkin's lymphoma
2009	Adelaide Health Technology Assessment (AHTA)	Cervista HPV 16/18 for the identification of strains of the human papillomavirus associated with cervical cancer
2009	Norwegian Knowledge Centre for the Health Services (NOKC)	[Laparoscopic surgery for benign gynaecological disease]
2009	NIHR Health Technology Assessment programme	Mifamurtide for osteosarcoma
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Botulinum toxin A for headaches in adults: a review of clinical-effectiveness and safety
2009	Andalusian Health Technology Assessment Area (AETSA)	[Clinical effectiveness of ozone therapies]
2009	HAYES, Inc.	Inpatient treatment for anorexia nervosa
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Fluocinolone acetonide intravitreal insert (Iluvien) for diabetic macular oedema